About us

ComfTech  is created as a non-participatory spin-off of the Milan Polytechnic University and of the textile company New Sirvip srl’s innovation branch. The first project of smart textile starts in the neonatal
intensive care wing in the Lecco hospital, with the aim of creating a wearable technology in order to improve the life of premature babies. In the same year, ComfTech ® obtains the first patent for a wearable
system with textile sensors and then the second patent for an innovative textile sensor capable of measuring a person’s vital parameters.

Completion of the first neonatal monitoring system study of the infant’s first two hours of life at the Manzoni Hospital in Lecco. In the same year ComfTech ® applies for a third patent for a sensor capable of
measuring physiological electrical signals.

This year marks the collaboration with both Italian and foreign research institutes for continuous monitoring projects through wearable systems. ComfTech ® is selected through phase 1 of a grant application, obtaining funding by the EU Horizon 2020 programme. The year 2015 also sees the beginning of a partnership for a new sensors system development (breathing rate, perspiration, printed electronics).
ComfTech ® also applies for its fourth patent.

ComfTech ® obtains the ISO 13485 certification. It initiates some distribution agreements and starts the
second clinical trial.

Between 2017 and beginning of 2018, the company starts looking for a financial partner who could offer support in order to complete the scientific validation process and also to develop and launch its products in the market. Moreover, it acquires some shares in Witsense srl and wins both “Somnus” and “Smart living & design” competitions.

ComfTech ® joins the EU Programme “Horizon 2020” and is committed to launch a large scale production business and marketing. The year 2018 is the company’s turning point, as the deal with the Italian financial fund Principia SGR is signed, through the fund Principia III – Health.

In 2019, the design of the Howdy Senior adult product and the first tests began in collaboration with the University of Brescia.

Amid the challenges of the COVID-19 pandemic, ComfTech continued to advance its medical technology and partnerships. In 2020, new clinical trials began at the Arezzo Hospital (neonatal ward) and Brescia Hospital (Howdy Senior), while the company achieved ISO Class II certification for adult and neonatal monitoring systems. Collaboration also expanded with NINA, the neonatal simulation center in Pisa, and ComfTech was selected for the DailyST and Hub Smart Cities innovation programs. That same year, the company launched BODEE BREATH, its first consumer product for continuous, non-invasive home monitoring.

During this period, ComfTech also certified the Howdy Senior medical device and developed its Cloud infrastructure and analysis tools, which continued to evolve throughout 2021.

In 2022 and 2023, ComfTech strengthened its structure and renewed its commitment to responsible innovation. The company conducted a thorough analysis of privacy and security, appointed a Data Protection Officer (DPO), and began the transition to MDR compliance. During this period, ComfTech also became a Benefit Corporation, achieving B Corp certification, and the founders regained full ownership of the company. Commercial activities resumed with a focus on the Italian market and testing initiatives in Belgium.

In 2024 and 2025, ComfTech expanded its clinical and technological activities, conducting hospital trials, collecting newborn data, and developing the HBHTA analysis with Politecnico di Milano. The company obtained MDR certification, extended HOWDY Baby for pediatric use, and participated in several European and national research projects, including ThrombUS+, GESTUS, VIPPSTAR, SFIDA, NASC-ITA, HOWDY Edge, and HPC4wearable.